Human libido and relationships are complex at their core, so it would be very difficult to extrapolate what it is about these medicines specifically that would have an impact there, says Dr Mark Mellor, a bariatric doctor and specialist GP who regularly prescribes GLP-1s and says research would be challenging
The top five most influenced health issues were mental burden, emotional distress, economic burden, weight lost, and appetite
GLP-1 medications like semaglutide and tirzepatide are possible treatment options that healthcare providers may consider for weight management during menopause
Also this is extrapolated data C) As a sell side analyst we have only seen cos upgrade their forecast for FY27 D) Inventory - the bigger cos / bigger brands are still selling and no inventory is visible
Hence, it was an open question whether or not a triple agonist like retatrutide would augment FOC in HAP
Whether you're considering retatrutide, already using it through clinical trials or compounding sources, or just trying to understand how these medications work, the triple-agonist mechanism explains both why it works so well and why it causes the side effects it does
